Industry Research Reports

Home > Reports > Medical Care > Ophthalmic Pharmaceutical Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Ophthalmic Pharmaceutical Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 105 Pages

Report ld: 2627513

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Ophthalmic Pharmaceutical Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Pharmaceutical Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ophthalmic Pharmaceutical Drugs by region & country, by Type, and by Application.

The Ophthalmic Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Pharmaceutical Drugs.

Market Segmentation

Report Metric
Details
Report Title
Ophthalmic Pharmaceutical Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Ophthalmic Pharmaceutical Drugs Companies Covered
Allergan PLC, Bayer AG, F. Hoffmann-La Roche AG, Johnson and Johnson Vision Care Inc, Kyowa Kirin Co., Ltd, Novartis International AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceuticals Co., Ltd., Shire PLC
Global Ophthalmic Pharmaceutical Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ophthalmic Pharmaceutical Drugs Market, Segment by Type
Prescription Drugs

Over-the-Counter Drugs
Global Ophthalmic Pharmaceutical Drugs Market, Segment by Application
Hospital Pharmacies

Drug Stores

Online Pharmacies

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ophthalmic Pharmaceutical Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Ophthalmic Pharmaceutical Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Ophthalmic Pharmaceutical Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Ophthalmic Pharmaceutical Drugs Product Introduction
    1.2 Global Ophthalmic Pharmaceutical Drugs Market Size Forecast
    1.3 Ophthalmic Pharmaceutical Drugs Market Trends & Drivers
        1.3.1 Ophthalmic Pharmaceutical Drugs Industry Trends
        1.3.2 Ophthalmic Pharmaceutical Drugs Market Drivers & Opportunity
        1.3.3 Ophthalmic Pharmaceutical Drugs Market Challenges
        1.3.4 Ophthalmic Pharmaceutical Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Ophthalmic Pharmaceutical Drugs Players Revenue Ranking (2023)
    2.2 Global Ophthalmic Pharmaceutical Drugs Revenue by Company (2019-2024)
    2.3 Key Companies Ophthalmic Pharmaceutical Drugs Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Ophthalmic Pharmaceutical Drugs Product Offered
    2.5 Key Companies Time to Begin Mass Production of Ophthalmic Pharmaceutical Drugs
    2.6 Ophthalmic Pharmaceutical Drugs Market Competitive Analysis
        2.6.1 Ophthalmic Pharmaceutical Drugs Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Ophthalmic Pharmaceutical Drugs Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Pharmaceutical Drugs as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Prescription Drugs
        3.1.2 Over-the-Counter Drugs
    3.2 Global Ophthalmic Pharmaceutical Drugs Sales Value by Type
        3.2.1 Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Ophthalmic Pharmaceutical Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Ophthalmic Pharmaceutical Drugs Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital Pharmacies
        4.1.2 Drug Stores
        4.1.3 Online Pharmacies
        4.1.4 Others
    4.2 Global Ophthalmic Pharmaceutical Drugs Sales Value by Application
        4.2.1 Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Ophthalmic Pharmaceutical Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Ophthalmic Pharmaceutical Drugs Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Ophthalmic Pharmaceutical Drugs Sales Value by Region
        5.1.1 Global Ophthalmic Pharmaceutical Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        5.2.2 North America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        5.3.2 Europe Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        5.4.2 Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        5.5.2 South America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        5.6.2 Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value
    6.3 United States
        6.3.1 United States Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.3.2 United States Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.4.2 Europe Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.5.2 China Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.6.2 Japan Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.7.2 South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Ophthalmic Pharmaceutical Drugs Sales Value, 2019-2030
        6.9.2 India Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Ophthalmic Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Allergan PLC
        7.1.1 Allergan PLC Profile
        7.1.2 Allergan PLC Main Business
        7.1.3 Allergan PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.1.4 Allergan PLC Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.1.5 Allergan PLC Recent Developments
    7.2 Bayer AG
        7.2.1 Bayer AG Profile
        7.2.2 Bayer AG Main Business
        7.2.3 Bayer AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.2.4 Bayer AG Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.2.5 Bayer AG Recent Developments
    7.3 F. Hoffmann-La Roche AG
        7.3.1 F. Hoffmann-La Roche AG Profile
        7.3.2 F. Hoffmann-La Roche AG Main Business
        7.3.3 F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.3.4 F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.3.5 Johnson and Johnson Vision Care Inc Recent Developments
    7.4 Johnson and Johnson Vision Care Inc
        7.4.1 Johnson and Johnson Vision Care Inc Profile
        7.4.2 Johnson and Johnson Vision Care Inc Main Business
        7.4.3 Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.4.4 Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.4.5 Johnson and Johnson Vision Care Inc Recent Developments
    7.5 Kyowa Kirin Co., Ltd
        7.5.1 Kyowa Kirin Co., Ltd Profile
        7.5.2 Kyowa Kirin Co., Ltd Main Business
        7.5.3 Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.5.4 Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.5.5 Kyowa Kirin Co., Ltd Recent Developments
    7.6 Novartis International AG
        7.6.1 Novartis International AG Profile
        7.6.2 Novartis International AG Main Business
        7.6.3 Novartis International AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.6.4 Novartis International AG Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.6.5 Novartis International AG Recent Developments
    7.7 Pfizer, Inc.
        7.7.1 Pfizer, Inc. Profile
        7.7.2 Pfizer, Inc. Main Business
        7.7.3 Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.7.4 Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.7.5 Pfizer, Inc. Recent Developments
    7.8 Regeneron Pharmaceuticals, Inc.
        7.8.1 Regeneron Pharmaceuticals, Inc. Profile
        7.8.2 Regeneron Pharmaceuticals, Inc. Main Business
        7.8.3 Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.8.4 Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.8.5 Regeneron Pharmaceuticals, Inc. Recent Developments
    7.9 Santen Pharmaceuticals Co., Ltd.
        7.9.1 Santen Pharmaceuticals Co., Ltd. Profile
        7.9.2 Santen Pharmaceuticals Co., Ltd. Main Business
        7.9.3 Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.9.4 Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.9.5 Santen Pharmaceuticals Co., Ltd. Recent Developments
    7.10 Shire PLC
        7.10.1 Shire PLC Profile
        7.10.2 Shire PLC Main Business
        7.10.3 Shire PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
        7.10.4 Shire PLC Ophthalmic Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
        7.10.5 Shire PLC Recent Developments

 8 Industry Chain Analysis
    8.1 Ophthalmic Pharmaceutical Drugs Industrial Chain
    8.2 Ophthalmic Pharmaceutical Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Ophthalmic Pharmaceutical Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Ophthalmic Pharmaceutical Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Ophthalmic Pharmaceutical Drugs Market Trends
    Table 2. Ophthalmic Pharmaceutical Drugs Market Drivers & Opportunity
    Table 3. Ophthalmic Pharmaceutical Drugs Market Challenges
    Table 4. Ophthalmic Pharmaceutical Drugs Market Restraints
    Table 5. Global Ophthalmic Pharmaceutical Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Ophthalmic Pharmaceutical Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Ophthalmic Pharmaceutical Drugs Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Ophthalmic Pharmaceutical Drugs Product Type
    Table 9. Key Companies Time to Begin Mass Production of Ophthalmic Pharmaceutical Drugs
    Table 10. Global Ophthalmic Pharmaceutical Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Pharmaceutical Drugs as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2019-2024) & (%)
    Table 27. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 31. Allergan PLC Basic Information List
    Table 32. Allergan PLC Description and Business Overview
    Table 33. Allergan PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Allergan PLC (2019-2024)
    Table 35. Allergan PLC Recent Developments
    Table 36. Bayer AG Basic Information List
    Table 37. Bayer AG Description and Business Overview
    Table 38. Bayer AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Bayer AG (2019-2024)
    Table 40. Bayer AG Recent Developments
    Table 41. F. Hoffmann-La Roche AG Basic Information List
    Table 42. F. Hoffmann-La Roche AG Description and Business Overview
    Table 43. F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of F. Hoffmann-La Roche AG (2019-2024)
    Table 45. F. Hoffmann-La Roche AG Recent Developments
    Table 46. Johnson and Johnson Vision Care Inc Basic Information List
    Table 47. Johnson and Johnson Vision Care Inc Description and Business Overview
    Table 48. Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Johnson and Johnson Vision Care Inc (2019-2024)
    Table 50. Johnson and Johnson Vision Care Inc Recent Developments
    Table 51. Kyowa Kirin Co., Ltd Basic Information List
    Table 52. Kyowa Kirin Co., Ltd Description and Business Overview
    Table 53. Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Kyowa Kirin Co., Ltd (2019-2024)
    Table 55. Kyowa Kirin Co., Ltd Recent Developments
    Table 56. Novartis International AG Basic Information List
    Table 57. Novartis International AG Description and Business Overview
    Table 58. Novartis International AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Novartis International AG (2019-2024)
    Table 60. Novartis International AG Recent Developments
    Table 61. Pfizer, Inc. Basic Information List
    Table 62. Pfizer, Inc. Description and Business Overview
    Table 63. Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Pfizer, Inc. (2019-2024)
    Table 65. Pfizer, Inc. Recent Developments
    Table 66. Regeneron Pharmaceuticals, Inc. Basic Information List
    Table 67. Regeneron Pharmaceuticals, Inc. Description and Business Overview
    Table 68. Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Regeneron Pharmaceuticals, Inc. (2019-2024)
    Table 70. Regeneron Pharmaceuticals, Inc. Recent Developments
    Table 71. Santen Pharmaceuticals Co., Ltd. Basic Information List
    Table 72. Santen Pharmaceuticals Co., Ltd. Description and Business Overview
    Table 73. Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Santen Pharmaceuticals Co., Ltd. (2019-2024)
    Table 75. Santen Pharmaceuticals Co., Ltd. Recent Developments
    Table 76. Shire PLC Basic Information List
    Table 77. Shire PLC Description and Business Overview
    Table 78. Shire PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Shire PLC (2019-2024)
    Table 80. Shire PLC Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Ophthalmic Pharmaceutical Drugs Downstream Customers
    Table 84. Ophthalmic Pharmaceutical Drugs Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Ophthalmic Pharmaceutical Drugs Product Picture
    Figure 2. Global Ophthalmic Pharmaceutical Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Ophthalmic Pharmaceutical Drugs Report Years Considered
    Figure 5. Global Ophthalmic Pharmaceutical Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Pharmaceutical Drugs Revenue in 2023
    Figure 7. Ophthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Prescription Drugs Picture
    Figure 9. Over-the-Counter Drugs Picture
    Figure 10. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Ophthalmic Pharmaceutical Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital Pharmacies
    Figure 13. Product Picture of Drug Stores
    Figure 14. Product Picture of Online Pharmacies
    Figure 15. Product Picture of Others
    Figure 16. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Ophthalmic Pharmaceutical Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value (%), (2019-2030)
    Figure 29. United States Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. Ophthalmic Pharmaceutical Drugs Industrial Chain
    Figure 51. Ophthalmic Pharmaceutical Drugs Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

The global market for Ophthalmic Pharmaceutical Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Pharmaceutical Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ophthalmic Pharmaceutical Drugs by region & country, by Type, and by Application.

The Ophthalmic Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Pharmaceutical Drugs.

Market Segmentation